BIOMAT Database Logo BIOMAT Database Logo

[Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation]. 1973

S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Adrenergic beta receptor blockaders in the treatment of angina pectoris].
October 1969, Hospital (Rio de Janeiro, Brazil),
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris].
March 1974, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Beta-receptor blockaders and angina pectoris].
August 1973, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[The treatment of angina pectoris with beta receptor blockaders].
March 1971, Medizinische Klinik,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Beta-blockaders and angina pectoris].
January 1978, Coeur et medecine interne,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 5. 2. Adrenergic beta receptor blockaders].
March 1980, Sygeplejersken,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
December 1973, Schweizerische medizinische Wochenschrift,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Beta-blockaders in first-intention treatment of exercise angina pectoris].
September 1987, Presse medicale (Paris, France : 1983),
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
Beta-adrenergic receptor blocking drugs in angina pectoris.
January 1974, Drugs,
S Lukasik, and K Wrabec, and K Stańkowska, and K Janicka
[Beta blockaders in different forms of angina pectoris].
January 1978, Cardiology,
Copied contents to your clipboard!